Sanofi India · NSE: SANOFI · BSE: 500674
Q2 FY21 results · Jul–Sep 2020
Sanofi India reported revenue from operations of ₹686.60 crore (down 11.9% from Q2 FY20) and net profit of ₹132.90 crore (up 5.0% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a standalone basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 686.60 | 779.10 | −11.9% | 710.50 | −3.4% |
| Other income | 14.90 | 22.90 | −34.9% | 29.20 | −49.0% |
| Total income | 701.50 | 802.00 | −12.5% | 739.70 | −5.2% |
| Profit before tax | 185.90 | 132.70 | +40.1% | 186.50 | −0.3% |
| Net profit for the period | 132.90 | 126.60 | +5.0% | 136.30 | −2.5% |
| EPS, basic (₹) | 57.71 | 54.96 | +5.0% | 59.18 | −2.5% |
| Net margin (%) | 19.4 | 16.2 | 19.2 |
Standalone
- Filed with BSE
- 28 Oct 2020, 12:47 IST
- Board meeting
- 27 Oct 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE